Opioid Analgesics and Mania Risk in Patients with Prior Mania History
Opioid analgesics including oxycodone and hydrocodone can trigger manic episodes in patients with a history of mania, and this risk appears to be clinically significant—occurring in approximately 27% of bipolar patients exposed to opioids in one study.
Evidence for Opioid-Induced Mania
The most direct evidence comes from a 2007 study showing that 9 out of 33 patients (27%) with known bipolar disorder experienced significant hypomanic/manic reactions when taking opioid analgesics for medical reasons, with two additional patients reporting antidepressant effects 1. Importantly, none of the comparison subjects without bipolar disorder reported significant mood reactions, suggesting this is a vulnerability specific to those with mood disorder history.
Multiple case reports and case series further support this association:
- A 2013 retrospective study identified 45 cases of mania precipitated by opioid withdrawal, including 28 patients experiencing their first manic episode 2
- Individual case reports document mania triggered by codeine/paracetamol combinations 3, tramadol 4, and codeine with erythromycin 5
Clinical Implications and Risk Assessment
When prescribing opioids to patients with prior mania, you must:
Recognize the heightened risk: Patients with personal or family history of bipolar disorder are at increased risk for substance-induced mood destabilization 6
Monitor intensively: The FDA label for oxycodone explicitly states that patients at increased risk (including those with mental illness such as major depression) "necessitates intensive counseling about the risks and proper use... along with intensive monitoring for signs of addiction, abuse, and misuse" 6
Watch for early warning signs: Mood elevation, decreased need for sleep, increased energy, racing thoughts, or impulsivity developing after opioid initiation
Consider the bipolar treatment guideline context: The 2007 practice parameter notes that "antidepressants may destabilize the patient's mood or incite a manic episode" and that "a manic episode precipitated by an antidepressant is characterized as substance induced per DSM-IV-TR" 7. This same principle applies to opioids with mood-elevating properties.
Mechanism and Clinical Context
The mood-elevating effects likely occur through opioid activation of reward pathways in the locus coeruleus and amygdala 8. The 2013 study on opioid withdrawal-induced mania suggests that opioids may have mood-stabilizing effects during chronic use, with mania emerging during withdrawal 2. However, the acute administration studies demonstrate that opioids can directly trigger mania during active use in susceptible individuals 1.
Practical Management Approach
If opioids are medically necessary despite mania history:
- Use the lowest effective dose for the shortest duration
- Ensure the patient is on adequate mood stabilizer therapy before initiating opioids
- Schedule frequent follow-up (weekly initially) to monitor for mood destabilization
- Educate patient and family about warning signs of mania
- Consider non-opioid alternatives aggressively (NSAIDs, acetaminophen, regional anesthesia, non-pharmacologic approaches)
- Document the risk-benefit discussion thoroughly
Common pitfall: Assuming that because the patient tolerated oxycodone or hydrocodone previously without incident, they are not at risk. The 27% incidence rate means most patients will not develop mania, but the risk remains substantial and unpredictable in individual cases.
The evidence does not support avoiding opioids entirely in patients with mania history when medically indicated for acute pain 8, but it demands heightened vigilance and proactive mood monitoring that many clinicians fail to implement.